Skip to main content
SURMODICS INC logo

SURMODICS INC — Investor Relations & Filings

Ticker · SRDX ISIN · US8688731004 LEI · 549300H76KXCAAGUS878 US Manufacturing
Filings indexed 1,062 across all filing types
Latest filing 2010-03-17 Director's Dealing
Country US United States of America
Listing US SRDX

About SURMODICS INC

https://www.surmodics.com/

Surmodics, Inc. provides performance-enhancing technologies for the healthcare industry, focusing on medical devices and in vitro diagnostics. The company is a leading provider of surface modification technologies, offering customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. In addition to its coatings business, Surmodics develops and commercializes a portfolio of vascular intervention medical devices for the treatment of peripheral arterial and venous disease, including thrombectomy and radial access platforms. The company also offers end-to-end contract development and manufacturing services. Its In Vitro Diagnostics (IVD) division supplies critical chemical components for immunoassays and microarrays, aiming to enhance the sensitivity and reproducibility of diagnostic tests.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2010-03-17 English
3 Filing
Director's Dealing
2010-03-17 English
4 Filing
Director's Dealing
2010-03-17 English
3 Filing
Director's Dealing
2010-03-17 English
4 Filing
Director's Dealing
2010-03-11 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes organizational and leadership changes, office closures, restructuring charges, and the departure of a senior officer. There is no detailed financial report or comprehensive financial statements included. The document also references a press release as an exhibit. The primary focus is on management changes and organizational restructuring, which aligns with announcements about changes in senior management or the board. Therefore, the most appropriate classification is 'Board/Management Information (MANG)'. The document length is 3685 characters, which is relatively short and consistent with an 8-K announcement rather than a full report.
2010-03-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.